Bottlenecks to clinical translation of direct brain-computer interfaces
Despite several decades of research into novel brain-implantable devices to treat a range of diseases, only two-cochlear implants for sensorineural hearing loss and deep brain stimulation for movement disorders-have yielded any appreciable clinical benefit. Obstacles to translation include technical...
Saved in:
Published in | Frontiers in systems neuroscience Vol. 8; p. 226 |
---|---|
Main Author | |
Format | Journal Article |
Language | English |
Published |
Switzerland
Frontiers Media S.A
02.12.2014
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Despite several decades of research into novel brain-implantable devices to treat a range of diseases, only two-cochlear implants for sensorineural hearing loss and deep brain stimulation for movement disorders-have yielded any appreciable clinical benefit. Obstacles to translation include technical factors (e.g., signal loss due to gliosis or micromotion), lack of awareness of current clinical options for patients that the new therapy must outperform, traversing between federal and corporate funding needed to support clinical trials, and insufficient management expertise. This commentary reviews these obstacles preventing the translation of promising new neurotechnologies into clinical application and suggests some principles that interdisciplinary teams in academia and industry could adopt to enhance their chances of success. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Reviewed by: Mikhail Lebedev, Duke University, USA; Dong Song, University of Southern California, USA This article was submitted to the journal Frontiers in Systems Neuroscience. Edited by: Ioan Opris, Wake Forest University, USA |
ISSN: | 1662-5137 1662-5137 |
DOI: | 10.3389/fnsys.2014.00226 |